The BioCanRx network is changing the face of cancer treatment
BioCanRx’s vision is to cure patients and enhance the quality of life of those living with cancer. We will do this by supporting world-class research in the area of immune oncology, and by accelerating to the clinic the most promising cancer immunotherapies designed to save lives and enable a better quality of life. Through an innovative, collaborative funding process BioCanRx is becoming a world-leader in the translation, manufacture and adoption of leading edge cancer immunotherapy treatments for the benefit of cancer patients.
Call for Expressions of Interest Now Open
BioCanRx is pleased to announce a Call for Expressions of Interest to bring forward in our Cycle II application in June 2019 to the federal government’s NCE Program.
BioCanRx and Partners Announce Funding for Eight New Projects
$22,564,174 announced in funding for new projects including two clinical trials, two Enabling Study projects, three Catalyst projects, and one Clinical, Social & Economic Impact project.
Smoothing the Road to the Clinic
How do immunotherapies go from the bench to bedside? Dr. Tania Bubela’s project outlines the hurdles and solutions to effective clinical translation.
